This section is not available in the published analysis.
Mesoblast: Audience
Mesoblast is a biotechnology company focused on developing innovative allogeneic cellular medicines using its proprietary mesenchymal lineage cell technology platform. The company aims to treat complex inflammatory diseases that are resistant to conventional standard care.